The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.
Also called NCT01423188
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 176 participants
- Registry
-
NCT01423188
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Africa
- Registry status
- Completed
Technical summary
Registry record NCT01423188. Randomized; triple masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation
- Acronym
- SUSTAIN
- Condition
- Coronary Artery Disease
- Condition
- Dyslipidemia
- Intervention (Drug)
- RVX000222
- Intervention (Drug)
- Placebo RVX000222
- Lead sponsor
- Resverlogix Corp
- Collaborator
- The Cleveland Clinic
Record details
- Record id
cardio:ct-nct01423188- Content hash
78fa5340a879f0f79fe1b0ebf2b74bb730fbc5971fbd7b7e88729655f85ff89f